Atlas Trials

Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea

Clinical trial NCT04091789 · UNKNOWN

Trial details

NCT number
NCT04091789
Sponsor
Pure Green
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
DysmenorrheaHeadache, MigraineFatigueNauseaMood Disturbance
Start date
2019-09-01
Primary completion
2020-03-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.